0.59
price up icon1.41%   0.0082
after-market 시간 외 거래: .59
loading
전일 마감가:
$0.5818
열려 있는:
$0.59
하루 거래량:
1.14M
Relative Volume:
0.50
시가총액:
$98.02M
수익:
$15.93M
순이익/손실:
$-64.59M
주가수익비율:
-0.7867
EPS:
-0.75
순현금흐름:
$-59.50M
1주 성능:
-11.66%
1개월 성능:
+16.10%
6개월 성능:
-9.30%
1년 성능:
-32.86%
1일 변동 폭
Value
$0.5801
$0.60
1주일 범위
Value
$0.58
$0.725
52주 변동 폭
Value
$0.45
$1.42

Veru Inc Stock (VERU) Company Profile

Name
명칭
Veru Inc
Name
전화
(312) 595-9123
Name
주소
2916 N. MIAMI AVENUE, MIAMI, FL
Name
직원
210
Name
트위터
@Veru_Pharma
Name
다음 수익 날짜
2024-08-08
Name
최신 SEC 제출 서류
Name
VERU's Discussions on Twitter

VERU을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VERU
Veru Inc
0.59 98.02M 15.93M -64.59M -59.50M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Veru Inc Stock (VERU) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-05-14 개시 B. Riley Securities Buy
2024-03-28 개시 Raymond James Outperform
2023-06-07 업그레이드 Jefferies Underperform → Hold
2021-04-13 개시 Jefferies Buy
2021-02-09 재확인 H.C. Wainwright Buy
2020-01-21 재확인 H.C. Wainwright Buy
2019-03-20 개시 Oppenheimer Outperform
2018-07-03 개시 Maxim Group Buy
모두보기

Veru Inc 주식(VERU)의 최신 뉴스

pulisher
Jun 18, 2025

Veru (NASDAQ:VERU) Stock Price Crosses Below 200 Day Moving AverageWhat's Next? - MarketBeat

Jun 18, 2025
pulisher
Jun 18, 2025

Investors Purchase High Volume of Put Options on Veru (NASDAQ:VERU) - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

Traders Buy High Volume of Put Options on Veru (NASDAQ:VERU) - MarketBeat

Jun 17, 2025
pulisher
Jun 17, 2025

Upward Trajectory: Veru Inc (VERU) Posts a Slidee, Closing at 0.60 - DWinneX

Jun 17, 2025
pulisher
Jun 17, 2025

Veru Inc. (NASDAQ:VERU) Stock Position Raised by Bank of America Corp DE - Defense World

Jun 17, 2025
pulisher
Jun 11, 2025

VERU’s 2023 Market Dance: Up 6.22% – Time to Invest? - investchronicle.com

Jun 11, 2025
pulisher
Jun 11, 2025

Veru to Participate in the Virtual BTIG Obesity Health Forum | V - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Veru to Participate in the Virtual BTIG Obesity Health Forum | VERU Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Veru Inc. to Engage with Investors at BTIG Obesity Health Forum on June 18, 2025 - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Veru to Participate in the Virtual BTIG Obesity Health Forum - The Manila Times

Jun 11, 2025
pulisher
Jun 10, 2025

Veru Inc.'s (NASDAQ:VERU) 28% Share Price Surge Not Quite Adding Up - simplywall.st

Jun 10, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Raises Stock Position in Veru Inc. (NASDAQ:VERU) - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

VERUProspectus Filed Pursuant to Rule 424(b)(5) (424b5) - mx.advfn.com

Jun 06, 2025
pulisher
Jun 06, 2025

Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8 - mx.advfn.com

Jun 06, 2025
pulisher
Jun 05, 2025

Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024 - mx.advfn.com

Jun 05, 2025
pulisher
Jun 05, 2025

Veru Sets Another Quarterly Record in Both Net Revenues and in Gross Profit for Fiscal 2021 Third Quarter - mx.advfn.com

Jun 05, 2025
pulisher
Jun 03, 2025

Is Veru Inc (NASDAQ: VERU) A Great Stock To Invest In? - Stocksregister

Jun 03, 2025
pulisher
Jun 03, 2025

Cetera Investment Advisers Boosts Holdings in Veru Inc. (NASDAQ:VERU) - Defense World

Jun 03, 2025
pulisher
May 31, 2025

Tootsie Roll among names set to join Russell 3000 Index, Growgeneration, Veru set to leave - MSN

May 31, 2025
pulisher
May 31, 2025

Veru Inc. (NASDAQ:VERU) Shares Sold by Northern Trust Corp - Defense World

May 31, 2025
pulisher
May 30, 2025

Beyond Meat, Plby among consumer staple names set to join Russell Microcap Index, Veru, Vital Farms to leave - Seeking Alpha

May 30, 2025
pulisher
May 29, 2025

Veru selects enobosarm 3mg dose for Phase 3 trials after positive study By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 28, 2025

Muscle-sparing obesity drug safe for Phase 3 trial, Veru says - BioPharma Dive

May 28, 2025
pulisher
May 28, 2025

Veru selects enobosarm 3mg dose for Phase 3 trials after positive study - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

Veru Reports Positive Safety Results From Phase 2B Quality Study - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Veru Reports Positive Safety Results from Phase 2b QUALITY Study - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Veru (VERU) Advances Enobosarm in Clinical Trials with Promising - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Veru’s enobosarm shows increased fat loss, muscle preservation and safety - TipRanks

May 28, 2025
pulisher
May 28, 2025

Veru, GameStop, Azul - TradingView

May 28, 2025
pulisher
May 28, 2025

Veru Inc. Announce Positive Topline Safety Data from Phase 2b QUALITY Study of Enobosarm Combined with Semaglutide - Nasdaq

May 28, 2025
pulisher
May 28, 2025

Veru Reports Positive Safety Results from Phase 2b QUALITY - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone - Yahoo Finance

May 28, 2025
pulisher
May 28, 2025

Veru (VERU) Advances Enobosarm in Clinical Trials with Promising Safety Data | VERU Stock News - GuruFocus

May 28, 2025
pulisher
May 26, 2025

Veru: Saving Muscle Mass Amidst The GLP-1 Drug Boom - Seeking Alpha

May 26, 2025
pulisher
May 24, 2025

B. Riley Forecasts Veru's Q4 Earnings (NASDAQ:VERU) - MarketBeat

May 24, 2025
pulisher
May 19, 2025

B. Riley Analysts Decrease Earnings Estimates for Veru - Defense World

May 19, 2025
pulisher
May 19, 2025

MPM Bioimpact LLC Acquires New Shares in Veru Inc. (NASDAQ:VERU) - MarketBeat

May 19, 2025
pulisher
May 16, 2025

Veru Target of Unusually Large Options Trading (NASDAQ:VERU) - Defense World

May 16, 2025
pulisher
May 15, 2025

Veru signals Q3 2025 regulatory clarity for enobosarm Phase 3 trial - MSN

May 15, 2025
pulisher
May 15, 2025

Veru (NASDAQ:VERU) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat

May 15, 2025
pulisher
May 14, 2025

Barclays PLC Acquires 21,738 Shares of Veru Inc. (NASDAQ:VERU) - Defense World

May 14, 2025
pulisher
May 14, 2025

Veru Inc. (NASDAQ:VERU) Stake Raised by Wells Fargo & Company MN - Defense World

May 14, 2025
pulisher
May 10, 2025

Veru Inc. (NASDAQ:VERU) Q2 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 09, 2025

Veru Inc. Reports Progress in Clinical Trials and Financials - TipRanks

May 09, 2025
pulisher
May 09, 2025

Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial ... - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial ... By GuruFocus - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial Challenges - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Earnings call transcript: Veru Inc. beats Q2 2025 EPS forecast, stock rises - Investing.com India

May 09, 2025
pulisher
May 09, 2025

Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress - GlobeNewswire

May 09, 2025
pulisher
May 08, 2025

Veru Q2 2025 Earnings Call Transcript - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Veru Inc. Earnings Call: Promising Results Amid Challenges - TipRanks

May 08, 2025

Veru Inc (VERU) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Veru Inc 주식 (VERU) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Rankowitz Michael L
Director
Feb 19 '25
Buy
0.58
54,721
31,919
250,000
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):